Literature DB >> 20147495

Promising rabies vaccine for postexposure prophylaxis in developing countries, a purified vero cell vaccine produced in china.

Chuanlin Wang1, Xiaowei Zhang, Qingkun Song, Kun Tang.   

Abstract

We evaluated the immunogenicity, safety, and antibody persistence of a Vero cell rabies vaccine manufactured in China, compared with those of Verorab. Adequate titers of antibody were observed for the two vaccines. ChengDa rabies vaccine could be a promising alternative vaccine for many developing countries which cannot afford expensive rabies vaccines.

Mesh：

Substances：

Year:  2010        PMID： 20147495      PMCID： PMC2849343          DOI： 10.1128/CVI.00433-09

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


  8 in total

1.  Developments in the production and application of rabies vaccine for human use in China.

Authors:  F T Lin; N Lina
Journal:  Trop Doct       Date:  2000-01       Impact factor: 0.731

Review 2.  Round table on epidemiology and control of fox rabies.

Authors:  U Kihm; A Flamand; P P Pastoret; E Peterhans
Journal:  Vet Microbiol       Date:  1992-11       Impact factor: 3.293

3.  Preventing the incurable: Asian rabies experts advocate rabies control.

Authors:  B Dodet
Journal:  Vaccine       Date:  2006-04-12       Impact factor: 3.641

4.  WHO Expert Committee on Rabies.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1992

5.  A microtest for the quantitation of rabies virus neutralizing antibodies.

Authors:  E Zalan; C Wilson; D Pukitis
Journal:  J Biol Stand       Date:  1979-07

6.  The role of veterinary epidemiology in the study of free-roaming dogs and cats.

Authors:  M R Slater
Journal:  Prev Vet Med       Date:  2001-03-29       Impact factor: 2.670

7.  Prevalence and control of zoonotic diseases: collaboration between public health workers and veterinarians in Burkina Faso.

Authors:  N D Coulibaly; K R Yameogo
Journal:  Acta Trop       Date:  2000-07-21       Impact factor: 3.112

Review 8.  Canine vaccination--providing broader benefits for disease control.

Authors:  Sarah Cleaveland; Magai Kaare; Darryn Knobel; M Karen Laurenson
Journal:  Vet Microbiol       Date:  2006-04-18       Impact factor: 3.293
  8 in total
  5 in total

1.  Persistence of rabies antibody 5 years after postexposure prophylaxis with vero cell antirabies vaccine and antibody response to a single booster dose.

Authors:  Xiaowei Zhang; Zhenggang Zhu; Chuanlin Wang
Journal:  Clin Vaccine Immunol       Date:  2011-07-13

2.  Immunogenicity, safety and antibody persistence of a purified vero cell cultured rabies vaccine (Speeda) administered by the Zagreb regimen or Essen regimen in post-exposure subjects.

Authors:  Nianmin Shi; Yibin Zhang; Huizhen Zheng; Zhenggang Zhu; Dingming Wang; Sihai Li; Yuhua Li; Liqing Yang; Junnan Zhang; Yunhua Bai; Qiang Lu; Zheng Zhang; Fengji Luo; Chun Yu; Li Li
Journal:  Hum Vaccin Immunother       Date:  2017-01-25       Impact factor: 3.452

3.  Safety, immunogenicity of lyophilized purified vero cell cultured rabies vaccine administered in Zagreb and Essen regimen in post-exposure subjects: A post-marketing, parallel control clinical trial.

Authors:  Lei Zhang; Shichun Huang; Li Cai; Zhenggang Zhu; Jian Chen; Sha Lu; Zerong Zhu; Man Zhang; Yuan Fang; Quan Hu
Journal:  Hum Vaccin Immunother       Date:  2021-02-25       Impact factor: 3.452

4.  Animal-associated exposure to rabies virus among travelers, 1997-2012.

Authors:  Philippe Gautret; Kira Harvey; Prativa Pandey; Poh Lian Lim; Karin Leder; Watcharapong Piyaphanee; Marc Shaw; Susan C McDonald; Eli Schwartz; Douglas H Esposito; Philippe Parola
Journal:  Emerg Infect Dis       Date:  2015-04       Impact factor: 6.883

5.  Challenges and needs for China to eliminate rabies.

Authors:  Wenwu Yin; Jie Dong; Changchun Tu; John Edwards; Fusheng Guo; Hang Zhou; Hongjie Yu; Sirenda Vong
Journal:  Infect Dis Poverty       Date:  2013-10-02       Impact factor: 4.520
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.